ANTIHYPERGLYCEMIC ACTIVITY OF Alphonsea Sclerocarpa Thw. IN STZ-INDUCED DIABETIC RATS Authors: Sudheer Kumar Dokuparthi* , T. Rama Mohan Reddy
ABSTRACT
Back ground and objectives: Alphonsea sclerocarpa a well-known traditional herb famous for its
immense use in folklore medicine. Since diabetes is the most ubiquitous health issue in the century,
the drive towards antidiabetic drug discovery is continued for decades. In this regard, the current
work is engrossed in determining the antihyperglycemic potential of A. sclerocarpa leaves.
Methods: Antihyperglycemic through the Streptozotocin-induced diabetic rat model was performed
and Glibenclamide was taken as standard, the flavonoid-rich fraction of A. sclerocarpa was given to
the animals in two doses (200 and 400 mg/kg body weight), and blood glucose and lipid levels were
analyzed along with histological studies. Phytochemical screening, total phenolic, flavonoid, and
tannin contents were determined to support this investigation. The antioxidant activity studies by
DPPH assay, NO free radical scavenging assay, and total antioxidant assay were also screened using
standard protocols.
Results: Preliminary phytochemical screening of the leaf extract exposed various secondary
metabolites. The results show that the plant is rich in polyphenolic contents and regularized blood
glucose levels at 200 mg/kg and 400mg/kg dose in 15 days. The biochemical studies disclosed that the
plant significantly improved the abnormal blood glucose and lipid profile. The histopathological study
sustenance the protective effect of the plant against diabetes.
Conclusion: To conclude, all the biochemical data professed that the flavonoid-rich fraction of A.
sclerocarpa is effective among all the extracts to give protection against oxidative stress and subsequent
improvement of the blood sugar levels, serum lipid parameters, and ?-cell recovery. The antioxidants of the
phytochemicals embedded in the extract may be responsible for the stated activity.
Key words: Alphonsea sclerocarpa; antioxidant; anti-hyperglycemic; acute toxicity; lipid profile Publication date: 25/09/2021 https://ijbpas.com/pdf/2021/September/MS_IJBPAS_2021_SEPT_SPCL_1053.pdfDownload PDFhttps://doi.org/10.31032/IJBPAS/2021/10.9.1053